HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹19 Cr | ₹27 Cr | ₹39 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of HESTER BIOSCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹34 Cr |
How is Consolidated Net Profit of HESTER BIOSCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 45.52 | |
| Mar2025 | ₹19 Cr | -29.06 | |
| Mar2024 | ₹27 Cr | -32.28 | |
| Mar2023 | ₹39 Cr | 14.20 | |
| Mar2022 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹2,084.5 Cr | 1.8% | 18.1% | 35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 1.8% |
18.1% |
35.9% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses